semaglutide and cardiovascular disease Shows Secondary Prevention Benefits in Patients Without Diabetes Semaglutide in Cardiometabolic Diseases: SELECTing

Researchers are also exploring the potential of SFN to modify gut microbiotatheir role in ASD and how SFNs microbiota-modulating effects could contribute to symptom relief

So we conducted an NMA to resolve this uncertainty and found the most effective drug for male infertility

Appetite, 57 (1), 237246

In triple-negative breast cancer, a very aggressive disease with a poor prognosis, the commensal microbiota Clostridiales and its metabolite trimethylamine-N-oxide (TMAO) colonize the mammary gland, being more abundant in tumors exhibiting an activated immune microenvironment (237)

Twice a month, we sit down for Ask Me Anything episodes to answer your health questions from the clinic lens

doi:10.1016/S0140-6736(15)60383-X DISCLAIMER: These statements have not been approved by the Food and Drug Administration